Commercial code

EQS-News: ​​​​​​​Daldrup & Söhne AG increases EBIT by 12.5 % in 2022

Retrieved on: 
Friday, June 2, 2023

The EBIT margin, based on total operating performance, was thus 5.0 % (3.4 %), in line with the forecast issued for the year under review (4 to 6 %).

Key Points: 
  • The EBIT margin, based on total operating performance, was thus 5.0 % (3.4 %), in line with the forecast issued for the year under review (4 to 6 %).
  • As already communicated, the Group's total operating performance of EUR 36.9 million was around EUR 5 million below the original forecast.
  • Daldrup & Söhne AG has successfully continued its path of financial and operational consolidation in 2022.
  • Daldrup & Söhne AG's business model is largely independent of economic cycles and characterized by a long-term order environment for public services.

Technicolor Creative Studios: Share capital reduction and reverse share split of Technicolor Creative Studios’ shares

Retrieved on: 
Wednesday, May 31, 2023

This reverse stock-split will have no impact on the amount of the Company's share capital, and will result in the division of the number of outstanding shares by one hundred (100).

Key Points: 
  • This reverse stock-split will have no impact on the amount of the Company's share capital, and will result in the division of the number of outstanding shares by one hundred (100).
  • The definitive number of New Shares to be issued as a result of the reverse share split will be recorded by the Board of Directors or by the Chief Executive Officer at the end of the reverse share split.
  • Non-consolidated Existing Shares will be delisted at the end of the reverse share split period.
  • Centralization: All transactions relating to the reverse share split will take place with Société Générale Securities Services, 32 rue du Champ de Tir, CS 30812, 44308 Nantes Cedex 3, appointed as agent for the centralization of reverse share split transactions.

Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 20, 2023

Retrieved on: 
Tuesday, May 30, 2023

The shareholders of Median Technologies (ALMDT:PA) (Paris:ALMDT) are invited to participate at the Shareholders’ Ordinary and Extraordinary General Meeting which will be held on Tuesday June 20, 2023, at 11:00 AM CEST at PDGB, 174 avenue Victor Hugo – 75116 Paris.

Key Points: 
  • The shareholders of Median Technologies (ALMDT:PA) (Paris:ALMDT) are invited to participate at the Shareholders’ Ordinary and Extraordinary General Meeting which will be held on Tuesday June 20, 2023, at 11:00 AM CEST at PDGB, 174 avenue Victor Hugo – 75116 Paris.
  • All useful information relating to this Shareholders’ General Meeting is regularly updated on Median Technologies’ website.
  • Shareholders may exercise their voting rights before the holding of the Shareholders’ General Meeting, either by returning their postal voting form, or by giving proxy.
  • The detailed procedures relating to the exercise of the right to vote are specified in the notice of the Shareholders’ General Meeting, available here on Median’s website
    The preliminary notice of the Shareholders’ General Meeting has been published in the BALO (Bulletin des annonces légales obligatoires) on May 15, 2023.

Results of the votes of the Combined Shareholders’ General Meeting of May 25, 2023

Retrieved on: 
Friday, May 26, 2023

The Combined Shareholders' Meeting was held on Thursday May 25, 2023 at 2 p.m. at Hôtel Oceania Le Jura, 14 avenue Foch, 21000 Dijon (France), under the chairmanship of Mr. Frédéric Cren, Chairman and Chief Executive Officer and cofounder of Inventiva.

Key Points: 
  • The Combined Shareholders' Meeting was held on Thursday May 25, 2023 at 2 p.m. at Hôtel Oceania Le Jura, 14 avenue Foch, 21000 Dijon (France), under the chairmanship of Mr. Frédéric Cren, Chairman and Chief Executive Officer and cofounder of Inventiva.
  • All the resolutions submitted to vote have been adopted by the shareholders.
  • of the French Commercial Code, the Combined Shareholders’ Meeting approved, without modification, the compensation policy for corporate officers as presented in the 2022 Universal Registration Document (Part 3.5.1, pages 160 and seq.).
  • Information on the results of the votes is detailed below:
    Total number of shares composing the share capital: 42 134 169
    Total number of shares with voting rights: 41 992 149

Opening of conciliation proceedings

Retrieved on: 
Monday, May 22, 2023

As of today, discussions with the holders of Rallye’s debts secured by Casino’s securities placed in trust (fiducie-sûreté) have not been successful yet.

Key Points: 
  • As of today, discussions with the holders of Rallye’s debts secured by Casino’s securities placed in trust (fiducie-sûreté) have not been successful yet.
  • Under these circumstances, the companies have decided to request the opening of a conciliation proceeding to benefit from a more protective legal framework in order to pursue discussions with their creditors.
  • The president of the Paris Commercial Court today opened conciliation proceedings to the benefit of Rallye, Foncière Euris, Finatis and Euris for an initial period of four months, possibly renewable for a further month, and appointed SELAFA MJA (Me Valérie Leloup-Thomas) and SELARL Fides (Me Bernard Corre) as conciliators (conciliateurs) and terminated the ad hoc mandate proceedings opened on 25 April 2023.
  • Without prejudice to the application of Article L.611-16 of the Commercial Code [1] , the conciliation proceeding will allow the companies Rallye, Foncière Euris, Finatis and Euris to request from the Court periods of grace (délais de grâce) pursuant to Article L.611-7 of the Commercial Code in the event that the above-mentioned secured debt holders trigger events of default resulting from the opening of conciliation proceedings with respect to Casino.

ERYTECH Provides Update on the Announced Combination with PHERECYDES

Retrieved on: 
Monday, May 15, 2023

In relation with the announced merger of PHERECYDES into ERYTECH (the “Proposed Merger”), ERYTECH and PHERECYDES entered into a merger agreement on May 15, 2023, pursuant to which PHERECYDES will be merged into ERYTECH and PHERECYDES shareholders will receive 15 new ERYTECH shares for every 4 PHERECYDES shares they own (the “Merger Agreement”).

Key Points: 
  • In relation with the announced merger of PHERECYDES into ERYTECH (the “Proposed Merger”), ERYTECH and PHERECYDES entered into a merger agreement on May 15, 2023, pursuant to which PHERECYDES will be merged into ERYTECH and PHERECYDES shareholders will receive 15 new ERYTECH shares for every 4 PHERECYDES shares they own (the “Merger Agreement”).
  • The annual general meetings of ERYTECH and PHERECYDES shareholders will be called upon to vote on the Proposed Merger on June 23, 2023.
  • The Proposed Merger is expected to close shortly after the approval by both ERYTECH and PHERECYDES shareholders.
  • Guy Rigaud, of 827,132 PHERECYDES shares to ERYTECH in consideration of 3,101,745 newly issued ERYTECH shares (the “Contribution”).

Technicolor Creative Studios: Combined General Shareholders’ Meeting held on May 15, 2023

Retrieved on: 
Monday, May 15, 2023

Combined General Shareholders’ Meeting held on May 15, 2023

Key Points: 
  • Combined General Shareholders’ Meeting held on May 15, 2023
    Paris (France), May 15, 2023 - Technicolor Creative Studios (Euronext Paris: TCHCS) (the "Company") announces that the Combined General Shareholders’ Meeting (the “Meeting”), chaired by Ms. Anne Bouverot, Chairperson of the Board of Directors, was held today at 2pm at the Urban Station-Espace du Centenaire, 189 rue de Bercy, 75012 Paris.
  • The company's shareholders have been strongly mobilized for this Meeting, which gathered a quorum of 81.72 %.
  • The Board of Directors of the Company, which met at the close of this Meeting, sincerely thanks all shareholders for their support.
  • The Board of Directors, which met after the Meeting, appointed Mrs. Cécile Davies as observer representing Pimco.

EQS-News: Dolkam Suja a.s.: CONVOCATION OF ORDINARY GENERAL MEETING

Retrieved on: 
Wednesday, May 3, 2023

Shareholder has the right to participate in and vote at general meeting.

Key Points: 
  • Shareholder has the right to participate in and vote at general meeting.
  • A shareholder attends the general meeting personally or represented by proxy holder based on a written proxy pursuant to Sec.
  • Template of the written proxy which can be used for proxy voting is attached to this convocation.
  • 190a CC nor the shareholders’ participation in and voting at the general meeting by electronic means pursuant to Sec.

Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 24, 2023

Retrieved on: 
Wednesday, May 3, 2023

In accordance with articles R.225-83 of the French Commercial Code, documents are available for the shareholders from the time the meeting is convened.

Key Points: 
  • In accordance with articles R.225-83 of the French Commercial Code, documents are available for the shareholders from the time the meeting is convened.
  • For any questions relating to the Annual General Meeting of May 24, 2023, shareholders are invited to send an email to [email protected] .
  • The conditions for holding and taking part in this Combined Shareholders’ General Meeting may evolve depending on the health, regulatory and legal requirements in place.
  • In general, shareholders are invited to regularly consult the section dedicated to the General Meeting on the Company's website www.sensorion.com .

EQS-News: Formycon publishes results for financial year 2022

Retrieved on: 
Friday, April 28, 2023

The annual report at Group level is published for the first time in accordance with IFRS (International Financial Reporting Standards).

Key Points: 
  • The annual report at Group level is published for the first time in accordance with IFRS (International Financial Reporting Standards).
  • Furthermore, a toxicity study has been initiated, which results are a prerequisite for entering the clinical development phase.
  • On December 31, 2022, the Formycon Group's financial figures had developed as follows: Group revenues, which in addition to Formycon AG also include the fully consolidated subsidiaries Formycon Project 201 GmbH, FYB202 Project GmbH, Formycon Project 203 GmbH, Bioeq GmbH and the 50% stake in Bioeq AG increased to a total of Euro 42.5 million (2021 IFRS: Euro 36.6 million) in the fiscal year 2022.
  • Formycon AG achieved revenues (HGB) of Euro 28.3 million in the financial year 2022 (2021 HGB: Euro 26.5 million).